Assessing Safety of Cervical Spine Fusion With NMP®

Starting soon

Conditions studied: Degenerative Disc Disease, Degenerative Spondylolisthesis, Spinal Stenosis Cervical

In brief

The goal of this retrospective chart review study is to assess safety of NMP® in the treatment of cervical spine degenerative conditions by assessing the incidence and nature of AEs in follow-up (minimum of 90 days and up to 2 year post-operatively) as well as reoperation rates.

Key facts

Study ID

NCT07245940

Run by

Red Rock Regeneration Inc.

People needed

300

Starts

2026-01-15

Expected to finish

2026-08-01

Last updated by the study team

2025-11-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients treated with NMP® for Cervical (C2-T1) Interbody fusion (2022-2025) at the study site.
• Minimum of 90-day post-operative follow up data available

You may not qualify if…

• Patients with no follow-up data within 3 months from the surgery date due to missed postoperative appointments.

Where it is running

• Alabama Back Institute — Jasper, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.